Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 20, 2018

SELL
$169.43 - $198.0 $11,182 - $13,068
-66 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$168.79 - $188.59 $11,140 - $12,446
66
66 $11,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track America First Investment Advisors, LLC Portfolio

Follow America First Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of America First Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on America First Investment Advisors, LLC with notifications on news.